发现非癌症药物的潜力:对多发性骨髓瘤患者来说是一个有前途的突破
Omar S Al-Odat1,2, Emily Nelson1,2, Tulin Budak-Alpdogan3
1Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ 08103, USA.
Cancers
|July 13, 2024
概括
药物再利用为治疗多发性骨髓瘤 (MM) 提供了一种具有成本效益的战略,多发性骨髓瘤是一种高死亡率和耐治疗性的癌症. 探索现有的非癌症药物加速了新的MM疗法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 多发性骨髓瘤 (MM) 是一种流行癌症,死亡率高,通常在晚期诊断.
- 目前的MM治疗面临挑战,原因是所有患者最终会出现耐药性和复发.
- 开发新的MM疗法是耗时且财务要求高的.
研究的目的:
- 审查多发性骨髓瘤 (MM) 治疗当前的趋势和挑战.
- 突出药物重用对MM的意义和潜力.
- 为了确定现有的非癌症药物具有抗髓瘤特性.
主要方法:
- 在瘤学中对药物重定向策略的文献综述.
- 用临床前和临床数据分析现有的非癌症药物.
- 检查MM中重定向药物向的治疗途径.
主要成果:
- 药物重新定位显著减少了新的MM治疗的开发时间和成本.
- 现有的非癌症药物在向MM进展和耐药性途径方面表现有前途.
- 塔利多米德是MM治疗中药物重用的一个成功例子.
结论:
- 重用非癌症药物是MM治疗的高效和成本效益的方法.
- 对现有药物的进一步研究可以加速开发新型MM疗法.
- 识别和验证重用药物对于克服MM治疗耐药性至关重要.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
